The Infected Blood Compensation Authority (IBCA) reported that it had paid £2.376 billion in compensation by 30 September 2026. Its latest monthly figures record 3,722 people paid, while the total value of offers made reached £2.979 billion. The authority published the update on 8 October.
Registrations and payments
IBCA said it had received 21,215 registrations of intent to make a claim since opening the service on 9 October 2025. Registrations are not the same as unique people or claims: some people may have registered more than once. The authority does not yet know the total number of people who may be eligible, and registration remains open for some groups.
The figures mark a further step in a process that moves people through several stages. At the end of September, 7,151 people had been asked to start a claim, 6,499 had started the process, 3,821 had received an offer and 3,722 had been paid. Those stage totals describe progress across groups; they should not be read as a prediction of how many registrations will ultimately result in an award.
Compared with the previous published snapshot, dated 25 August, the end-September total was 728 higher for registrations of intent and 210 higher for people paid. The value of offers rose by about £137.7 million between the snapshots, while payments increased by about £117.3 million. These are differences between reported cumulative totals, not amounts attributable to a single day or a measure of the value of individual awards.
Different groups move at different rates
The update separates living infected people already registered with an existing support scheme from people who have never been compensated, affected people, and people acting for someone who died after infection. The largest paid total was among living infected people registered with a support scheme: 3,289 people had been paid, with £2.127 billion paid to that group. The authority had also paid 120 people in the living-infected-never-compensated group, 169 affected people and 144 people acting on behalf of a deceased infected person.
These categories reflect different circumstances and stages of access to the scheme. The authority said it had asked every living infected person registered by the end of September to start a claim. It had started over half of known deceased infected claims and was inviting people in higher-priority groups who had registered since mid-August. For living affected claims, all end-of-life claims had been started and work was beginning with people aged over 75. The figures therefore combine progress that is further advanced for some groups with claims still waiting to enter the process.
What the totals include
The overall payment total comprises £1.623 billion through the core route and £752.5 million through the adjusted route. Under the core route, a person receives a lump sum and, if registered with a support scheme, may choose to stop regular lifetime support payments. Some lump sums can be paid in instalments. Under the adjusted route, eligible people receive an adjusted lump sum while continuing to receive regular support-scheme payments. The £752.5 million figure counts the IBCA payment, not those continuing support payments.
A supplementary route is intended for exceptional cases where a core award does not fully reflect financial losses or care costs. The authority said it was preparing to open that service; the current totals are not a measure of supplementary awards.
The scheme was established following the Infected Blood Inquiry’s recommendation for compensation for people infected through contaminated blood, blood products or tissue, and people affected through their relationship with someone infected. The inquiry examined harm linked to medical treatment in earlier decades. This update concerns the administration of claims and payments; it does not change the history of that harm or determine any individual claim.
New regulations became law on 24 July 2026 and were implemented in the claims service from 1 October. IBCA said the rules would be applied to claims already in progress and that previously paid claims would be reviewed where relevant. It planned to complete most updates to previously paid core infected claims by the end of March 2027. Its next statistics release is scheduled for 12 November and will cover October.
